pennystocktracker
08-27-2009, 04:27 PM
HEY
.Immunomedics, Inc (NASDAQ:IMMU) soared over 59.6% in the early trading hour. The stock is currently trading at $6.80 on a volume of 1.48 million shares. Today (August 27, 2009), UCB Group and Immunomedics, Inc announced top-line results from UCB's phase IIb clinical study comparing epratuzumab to placebo in patients with systemic lupus erythematosus (SLE, also commonly known as lupus).
.
You can also check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!
You can also check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!